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Most Helicobacter pylori strains are susceptible to amoxicillin, an important component of combination
therapies for H. pylori eradication. The isolation and initial characterization of the first reported stable
amoxicillin-resistant clinical H. pylori isolate (the Hardenberg strain) have been published previously, but the
underlying resistance mechanism was not described. Here we present evidence that the -lactam resistance of
the Hardenberg strain results from a single amino acid substitution in HP0597, a penicillin-binding protein 1A
(PBP1A) homolog of Escherichia coli. Replacement of the wild-type HP0597 (pbp1A) gene of the amoxicillin-
sensitive (Amxs) H. pylori strain 1061 by the Hardenberg pbp1A gene resulted in a 100-fold increase in the MIC
of amoxicillin. Sequence analysis of pbp1A of the Hardenberg strain, the Amxs H. pylori strain 1061, and four
amoxicillin-resistant (Amxr) 1061 transformants revealed a few amino acid substitutions, of which only a single
Ser4143Arg substitution was involved in amoxicillin resistance. Although we cannot exclude that mutations in
other genes are required for high-level amoxicillin resistance of the Hardenberg strain, this amino acid
substitution in PBP1A resulted in an increased MIC of amoxicillin that was almost identical to that for the
original Hardenberg strain.
Helicobacter pylori, a spiral-shaped gram-negative bacte-
rium which colonizes the human stomach, is the causative
agent of chronic active gastritis and peptic ulcer disease and
is associated with increased risk for gastric cancer and gas-
tric lymphoma (3, 9, 21). Anti-H. pylori therapy often con-
sists of the -lactam antibiotic amoxicillin in combination
with one or more antimicrobial drugs, a bismuth compo-
nent, and/or a proton pump inhibitor (9, 12). H. pylori is
usually sensitive to amoxicillin, but occasionally strains for
which an increased MIC is observed have been reported.
The first reported amoxicillin-resistant (Amxr) strains (MIC
 256 mg/liter) were isolated from dyspeptic patients in
Italy and the United States (10), but they all rapidly lost
their amoxicillin resistance in vitro (8). Subsequently the
isolation of a stable amoxicillin-resistant clinical H. pylori
isolate, the Hardenberg strain, from an 82-year-old Dutch
dyspeptic patient was reported (27).
Bacterial resistance against -lactam antibiotics results
mostly from either the production of -lactamase (16),
structural alterations in one of the penicillin-binding pro-
teins (PBPs) (24), or changes in other proteins involved in
cell wall synthesis (4, 17, 29). Initial studies with H. pylori
indicated the presence of three high-molecular-weight
PBPs, designated PBP1A, PBP2, and PBP3 (5). Later a
fourth, low-molecular-weight PBP, PBP4, was identified
(14), and subsequently five other potential PBPs (13) and an
H. pylori-specific -lactamase (19) have been described.
Amoxicillin resistance in H. pylori was found not to rely on
the acquisition or expression of -lactamase (8, 27). The
nonstable amoxicillin resistance of H. pylori (8) is probably
due to a decreased expression of the penicillin-binding pro-
tein PBPD (7). In the recently described in vitro-selected
Amxr H. pylori strains, amoxicillin resistance was suggested
to result from alterations in PBP1A (6, 22).
In this study, we describe the molecular mechanism of
amoxicillin resistance of the Hardenberg strain. Ten genes
from the published H. pylori genomes were selected as poten-
tial candidates based on their putative role in cell wall synthesis
(Table 1). After genetic transformation of the amoxicillin-sen-
sitive (Amxs) strain 1061 with PCR products of the selected
candidate genes of the Amxr Hardenberg strain, the minimal
PCR fragment able to transfer amoxicillin resistance was se-
quenced and the amino acid alterations responsible for amoxi-
cillin resistance were identified.
MATERIALS AND METHODS
Bacterial strains and growth conditions. H. pylori strains used in this study
were the Amxr Hardenberg strain (27) and the Amxs H. pylori strains 1061 (11),
J99 (2), 26695 (25), and SS1 (15). Bacteria were routinely grown on Columbia
agar plates (Becton Dickinson, Cockeysville, Md.) supplemented with 7% lysed
horse blood (BioTrading, Mijdrecht, The Netherlands) and H. pylori-selective
supplement (Oxoid, Basingstoke, United Kingdom) for 48 to 72 h at 37°C in an
atmosphere of 5% O2, 10% CO2, and 85% N2. Escherichia coli strain DH5
MCR (Life Technologies BV, Paisley, United Kingdom) was grown on Luria-
Bertani agar plates (23) for 24 h at 37°C in an aerobic environment. Selection of
E. coli DH5 MCR transformed with pGEM-T Easy clones was performed on
ampicillin-containing (100 mg/liter) Luria-Bertani agar plates.
Determination of MIC. The MIC was routinely determined by E-test (AB
Biodisk, Solna, Sweden) (10) or by agar dilution (8).
DNA manipulation. Recombinant DNA techniques were performed accord-
ing to standard protocols (23). PCR fragments and pGEM-T Easy clones were
sequenced on an Amersham Vistra 725 DNA sequencer using Thermo-Seque-
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nase premixed cycle sequencing kit (Amersham, Buckinghamshire, United King-
dom).
Natural transformation of H. pylori. Bacteria were transformed with approx-
imately 1 g of total DNA or 200 to 500 ng of PCR product essentially as
described by Wang et al. (28). Transformants were selected on Dent plates
containing 0.2 to 2 mg of amoxicillin (Sigma Aldrich Chemie, Zwijndrecht, The
Netherlands) per liter. As a control, bacteria were transformed with Tris-EDTA
(TE) (1 mM Tris-HCl [pH 8.0], 0.1 mM EDTA) or DNA from the Amxs strain
1061.
PCR. The oligonucleotide primers (Isogen, Maarsen, The Netherlands) used
in this study are indicated in Table 1 and Fig. 1. PCR was performed in an
automated thermal cycler (GeneAmp PCR system 9700; Perkin-Elmer), using
the PCR-core system I (Promega, Madison, Wis.).
Site-directed mutagenesis. Four different 135-bp oligonucleotides (Isogen)
were designed based on the sequence of pbp1A of H. pylori strain 1061, except
that they contained mismatches resulting in none, one, or two amino acid sub-
stitutions (Glu4063Ala and/or Ser4143Arg). For amplification, 5 pmol of the
135-bp oligonucleotides was used as template, with 25 pmol of each terminal
primer (5-GCTATTCCACGACTTCTAAA-3 and 5-GCAAGGTTACAAGC
CCTAAA-3).
Nucleotide sequence accession numbers. The pbp1A sequences of the H. pylori
Hardenberg and 1061 strains have been deposited into the GenBank database
under accession no. AF479617 and AF479618, respectively.
RESULTS AND DISCUSSION
Determination of the MICs of various antibiotics. The
MICs of the four antibiotics commonly used in anti-H. pylori
therapy, as well as several -lactam antibiotics, are presented
in Table 2. For the Hardenberg strain, the MIC of amoxicillin
was 8 mg/liter, while the MIC for strain 1061 was well below
0.016 mg/liter. The MICs of the other -lactam antibiotics
were significantly higher for the Hardenberg strain than for H.
TABLE 1. Transformation with PCR products of putative Amxr genes
Putative function of selected gene (gene name)a Gene no.b Position of fragmentc Transformation frequencyd
Penicillin-binding protein (pbp4) HP0160 168848–169882 None
H. pylori cysteine-rich protein A (hcpA) HP0211 218980–218291 None
Lysis tolerance protein (lytB) HP0400 411955–411354 None
Penicillin-binding protein (pbp1A) HP0597 632742–631000 5  106
Rod shape-determining protein (rodA1) HP0743 798879–797794 None
Rod shape-determining protein (mreC) HP1372 1436921–1436354 None
Rod shape-determining protein (mreB) HP1373 1438015–1437011 None
Cell division protein (ftsI) HP1556 1639818–1638044 None
Penicillin-binding protein (pbp2) HP1565 1648924–1647271 None
Methicillin resistance protein (llm) HP1581 1660483–1659552 None
a Genes were selected from the published H. pylori genomes (2, 25) as potential candidates based on their putative role in cell wall synthesis.
b HP gene numbers corresponding to the H. pylori 26695 genome sequence (25).
c Position of duplicated fragment, corresponding to the H. pylori 26695 genome sequence (25). Primers used for the amplification of the PCR fragments started at
the outside of the fragment and had each a length of 20 bp.
d Determined as the number of Amxr colonies per microgram of DNA per recipient CFU. Data represent the means of three experiments.
FIG. 1. Identification of the region of pbp1A required for amoxicillin resistance. Transformants were obtained by transformation of overlapping
PCR fragments of the Amxr Hardenberg strain to the Amxs strain 1061. The transformation frequency was determined as the number of Amxr
colonies per microgram of DNA per recipient CFU. Data represent the means of three experiments. Primers used for the amplification of the
smaller overlapping PCR fragments started at the outside of the fragment and had each a length of 20 bp. The first and last fragments (hatched
areas) partially consist of the flanking genes of pbp1A, namely, HP0596 and HP0598.
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pylori strain 1061. MICs of clarithromycin and tetracycline
were identical for both strains, but the Hardenberg strain was
found to be sensitive to metronidazole, while strain 1061 is
known to be resistant to that drug (11).
As the E-test was reported to generate discrepant results
when compared to the agar dilution method (1, 20, 26), and as
the E-test does not allow determination of amoxicillin MICs
below 0.016 mg/liter, the susceptibility to amoxicillin was also
tested by agar dilution. The MIC of amoxicillin for the Hard-
enberg strain by agar dilution was slightly higher (10 mg/liter)
than by E-test. For H. pylori strain 1061, the MIC of amoxicillin
was 0.01 mg/liter.
Transfer of amoxicillin resistance by natural transforma-
tion. Transformation of H. pylori strain 1061 with total DNA of
the Hardenberg strain resulted in Amxr colonies at a frequency
of 105. The MICs of amoxicillin for 10 randomly selected
transformants (obtained from three independent transforma-
tion experiments) as determined by E-test (Table 2) and agar
dilution were 0.75 and 1.0 mg/liter, respectively. In the agar
dilution method, for these transformants the MIC of amoxicil-
lin was 100-fold higher than that for the 1061 acceptor strain,
and it was only slightly lower than that of the Hardenberg
donor strain. For the Amxr transformants, the MICs of the
other -lactam antibiotics also displayed increases (Table 2).
Transformation with PCR products of cell wall synthesis-
encoding genes. Based on their putative role in cell wall syn-
thesis, 10 genes from the published H. pylori genome sequences
of strain 26695 (25) and strain J99 (2) were selected as poten-
tial Amxr genes (Table 1). Amxs strain 1061 was transformed
with PCR-amplified products of the selected genes of the Amxr
Hardenberg strain. Only transformation with pbp1A resulted in
Amxr colonies with a frequency of 5  106 (Table 1). PCR
products of the other putative amoxicillin resistance genes, TE,
and DNA from strain 1061 were each unable to transfer amoxi-
cillin resistance. The MIC of amoxicillin for 10 randomly se-
lected Amxr colonies (obtained from three independent trans-
formation experiments) was identical to that of strain 1061
transformed with total DNA of the Hardenberg strain. Re-
peated transformation of these transformants with either the
total DNA or the other nine PCR products of the Hardenberg
strain did not result in an increase of the MIC (data not
shown). The MIC for these transformants could be increased
to the same level as the Hardenberg strain only by continued
exposure to amoxicillin, but this additional increase of the
resistance was not stable. This indicated that the additional
increase in the MIC of amoxicillin for the Amxr 1061 transfor-
mants was due to a transient physiological change. Apparently
a stable increase of amoxicillin resistance to the level of the
Hardenberg strain requires mutations in more than one locus,
and the likelihood that these are all transferred by transfor-
mation is relatively small.
Identification of pbp1A mutations involved in amoxicillin
resistance. To determine the mutations of pbp1A responsible
for amoxicillin resistance, natural transformation experiments
were performed by using small overlapping PCR fragments of
pbp1A (Fig. 1). Amxr 1061 transformants (7  107) were
observed only with the 361-bp DNA fragment that spanned
nucleotides 953 to 1313 (numbering according to pbp1A of H.
pylori strain 26695). No Amxr colonies were observed after
transformation with the seven other pbp1A fragments, TE, or
DNA from strain 1061. The MIC of amoxicillin for 10 ran-
domly selected transformants (obtained from three indepen-
dent transformation experiments) was 1.0 mg/liter.
Analysis of PBP1A sequences obtained from the Harden-
berg strain, the Amxs 1061 strain, and four Amxr 1061 trans-
formants (obtained from three independent transformation
experiments with total DNA from the Hardenberg strain)
showed several amino acid substitutions in the Hardenberg
strain as well as in the transformants that did not occur in
the Amxs strain. Three transformants had incorporated the
complete Hardenberg pbp1A sequence, while the fourth
transformant contained only the second half of the gene.
For this fourth transformant the DNA exchange apparently
occurred between nucleotides 793 and 854. This was inde-
pendent proof that the first 792 bp of pbp1A of the Hard-
enberg strain are not involved in amoxicillin resistance, as
was already indicated by transformation with the pbp1A
PCR fragments.
Amoxicillin resistance of pbp1A is due to the Ser4143Arg
substitution. Sequence analysis of PBP1A showed two amino
acid differences in the region between nucleotides 953 and
1313, a glutamic acid by an alanine (Glu4063Ala) and a serine
by an arginine (Ser4143Arg). In order to identify which of
these amino acid changes was responsible for the increase in
amoxicillin resistance, site-directed mutagenesis was used.
Strain 1061 was transformed with four different 135-bp frag-
ments coding for amino acids 381 to 426 (numbering according
to pbp1A of H. pylori strain 26695 [25]) containing either no,
one (Glu4063Ala or Ser4143Arg), or both substitutions. Amx
r
colonies were observed only after natural transformation with
the two fragments that contained the Ser4143Arg substitution
with transformation frequencies of 7  108 and 4  108
respectively. Sequence analysis of PBP1A of four randomly
selected transformants, obtained from two independent trans-
formation experiments with the 135-bp Ser4143Arg fragment,
confirmed that only this substitution was present in the Amxr
transformants. The MIC of amoxicillin for these transformants
was 1.0 mg/liter. In addition to the MICs of amoxicillin for
these organisms, the growth rates (optical density at 600 nm
measured at regular intervals during a time period of 48 h),
sizes, and shapes of the bacteria were determined. In the ab-
TABLE 2. MICs for the Hardenberg strain, H. pylori strain 1061,






Amoxicillin 8 	0.016 0.75
Amoxicillin-clavulanate 2 	0.016 0.25
Cefotaxime 0.75 0.023 0.75
Ceftazidime 4 0.25 3
Penicillin 2 0.032 0.25
Piperacillin 4 	0.016 0.38
Clarithromycin 	0.016 	0.016 	0.016
Metronidazole 0.023 192 192
Tetracycline 	0.016 0.023 0.032
a Data shown are the averages of three separate experiments.
b MICs are the averages of 10 randomly selected transformants (obtained after
transformation with total DNA of the Hardenberg strain) derived from three
independent transformation experiments.
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sence of amoxicillin, no differences between the Hardenberg
strain, the four Amxr transformants, and strain 1061 were
found in growth rates, sizes, or shapes of the bacteria. Under
amoxicillin pressure (1 mg/liter), the bacteria became a little
bit shorter and thicker, but in spite of this morphological
change there was no significant change in growth rates (data
not shown).
Site-directed mutagenesis indicated that the Ser4143Arg
substitution in PBP1A represents the main factor in amoxi-
cillin resistance of the Hardenberg strain. Recently, other
investigators (22) reported that amino acid substitutions
Tyr4843Cys, Thr5413Ile, and Pro6003Thr in PBP1A are
responsible for amoxicillin resistance of an in vitro-selected
Amxr H. pylori strain. None of these amino acid substitu-
tions play a role in amoxicillin resistance of the Hardenberg
strain, since these substitutions were not present in the
Amxr Hardenberg strain. Further, the Ser4143Arg substitu-
tion in PBP1A in the Hardenberg strain and Amxr 1061
transformants had no influence on the expressed amount of
PBP1A molecules compared to the wild-type PBP1A of H.
pylori strain 1061 (data not shown). Probably the amino acid
substitutions in PBP1A of the Hardenberg strain and the in
vitro-selected Amxr strain (22) affect the binding affinity of
PBP1A for penicillins, but this was not tested.
Role of pbp1A in amoxicillin resistance of other H. pylori
strains. To test the generality of our findings, we also trans-
formed H. pylori strains J99, 26695, and SS1 (MICs of amoxi-
cillin for these strains, 0.01, 0.01, and 0.2 mg/liter, respectively)
either with the PCR product of pbp1A or with total DNA from
the Hardenberg strain. With all strains, Amxr transformants
were isolated at high frequency. Ten Amxr transformants of
each strain (obtained from two independent transformation
experiments) were selected at random, and the MICs of amoxi-
cillin were determined. All transformants had a MIC of 1.0
mg/liter, which was identical to the MIC of the Amxr H. pylori
1061 transformants but lower than the MIC of the Amxr Hard-
enberg strain. These results indicated that for strains other
than 1061, the introduction of the pbp1A from the Hardenberg
strain also increased the MIC of amoxicillin.
The results of our study showed that a single serine-to-
arginine substitution in PBP1A induces high-level amoxicil-
lin resistance in H. pylori. Since the existence of H. pylori
strains with a moderate resistance level against amoxicillin
already has been reported (18, 30) and apparently a single
mutation is sufficient to increase the MIC of amoxicillin, an
increase of naturally occurring H. pylori strains with a high
level of amoxicillin resistance can be expected in the near
future.
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